Literature DB >> 3100884

Interleukin-2 versus phorbol-ester-induced cellular events in normal T-lymphocytes.

B Friedrich, M Lundström, M Gullberg.   

Abstract

Activation of primary T-lymphocytes (T-cells) is dependent on interactions with the T3/T-cell antigen receptor complex which results in expression of cell surface receptors for the lymphocytotrophic growth factor interleukin-2 (IL-2). In the present communication we have compared the cellular responses to phorbol ester with IL-2-induced cellular responses. Thus, the effect of respective ligand on T-cell growth, the level of expression and composition of two distinct affinity classes of IL-2 receptors, and phosphorylation of an 80,000 mol. wt cellular substrate for the Ca2+-dependent, phospholipid-dependent protein kinase C (PK-C) was analysed. The results demonstrate that only the high affinity IL-2 receptor class is induced by phorbol esters and that both IL-2 and cell surface expression of its high affinity receptor is required for induction of low affinity IL-2 receptors. Moreover, IL-2 receptor signalling seems not to involve activation of PK-C and the results suggest that another intracellular pathway, distinct from the PK-C pathway which induces high affinity IL-2 receptors, is employed in the transmission of IL-2 growth promoting signals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100884     DOI: 10.1007/bf02935000

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  30 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Phorbol diester receptor copurifies with protein kinase C.

Authors:  J E Niedel; L J Kuhn; G R Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

6.  Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.

Authors:  J M Depper; W J Leonard; M Krönke; P D Noguchi; R E Cunningham; T A Waldmann; W C Greene
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.

Authors:  T Hunter; N Ling; J A Cooper
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

8.  Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover.

Authors:  A Kishimoto; Y Takai; T Mori; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

9.  Interleukin 2 induces rapid phosphorylation of cellular proteins in murine T-lymphocytes.

Authors:  M Kohno; S Kuwata; Y Namba; M Hanaoka
Journal:  FEBS Lett       Date:  1986-03-17       Impact factor: 4.124

10.  Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2.

Authors:  M Gullberg; K A Smith
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

View more
  1 in total

1.  Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains.

Authors:  F Grassi; R Meneveri; M Gullberg; L Lopalco; G B Rossi; P Lanza; C De Santis; G Brattsand; S Buttò; E Ginelli
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.